Crescita Free Cash Flow Yield from 2010 to 2026
| CTX Stock | CAD 0.47 0.02 4.08% |
Free Cash Flow Yield | First Reported 2010-12-31 | Previous Quarter 0.12 | Current Value 0.13 | Quarterly Volatility 0.50202432 |
Check Crescita Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Crescita Therapeutics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.2 M, Interest Expense of 55.6 K or Selling General Administrative of 10.5 M, as well as many indicators such as Price To Sales Ratio of 0.62, Dividend Yield of 0.0 or PTB Ratio of 0.67. Crescita financial statements analysis is a perfect complement when working with Crescita Therapeutics Valuation or Volatility modules.
Crescita | Free Cash Flow Yield |
Evaluating Crescita Therapeutics's Free Cash Flow Yield across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into Crescita Therapeutics's fundamental strength.
Latest Crescita Therapeutics' Free Cash Flow Yield Growth Pattern
Below is the plot of the Free Cash Flow Yield of Crescita Therapeutics over the last few years. It is a financial solvency ratio that compares the free cash flow per share a company is expected to earn against its market value per share, calculated as free cash flow per share divided by market price per share. Crescita Therapeutics' Free Cash Flow Yield historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Crescita Therapeutics' overall financial position and show how it may be relating to other accounts over time.
| Free Cash Flow Yield | 10 Years Trend |
|
Free Cash Flow Yield |
| Timeline |
Crescita Free Cash Flow Yield Regression Statistics
| Arithmetic Mean | (0.32) | |
| Coefficient Of Variation | (157.04) | |
| Mean Deviation | 0.43 | |
| Median | (0.18) | |
| Standard Deviation | 0.50 | |
| Sample Variance | 0.25 | |
| Range | 1.7345 | |
| R-Value | 0.70 | |
| Mean Square Error | 0.14 | |
| R-Squared | 0.49 | |
| Significance | 0 | |
| Slope | 0.07 | |
| Total Sum of Squares | 4.03 |
Crescita Free Cash Flow Yield History
About Crescita Therapeutics Financial Statements
Crescita Therapeutics investors utilize fundamental indicators, such as Free Cash Flow Yield, to predict how Crescita Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Free Cash Flow Yield | 0.12 | 0.13 |
Other Information on Investing in Crescita Stock
Crescita Therapeutics financial ratios help investors to determine whether Crescita Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Crescita with respect to the benefits of owning Crescita Therapeutics security.